- Report
- March 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- August 2024
- 150 Pages
Global
From €2634EUR$2,789USD£2,240GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4486EUR$4,750USD£3,815GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Glipizide is a drug used to treat type 2 diabetes, a condition in which the body does not produce or use insulin properly. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin. Glipizide is used to help control blood sugar levels in people with type 2 diabetes. It is usually taken once or twice a day with meals.
Glipizide is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat conditions such as diabetes, thyroid disorders, and obesity. These drugs are used to help regulate hormones and metabolism, and can help improve quality of life for those with these conditions.
Companies in the Glipizide market include Merck, Pfizer, Sanofi, and Novo Nordisk. Show Less Read more